I have a new situation: Two researches studied living organisms, Joe studied eukaryotes, while Bill studied prokaryotes. They were fascinated by genetic variation. But I can use this background: Prokaryotes have a different way to increase genetic variation. It's called genetic transfer or bacterial conjugation . It can occur in two ways. One way is when cells "grab" stray pieces of DNA from their environment. The other way is when cells directly exchange DNA (usually plasmids) with other cells. For example, as shown in Figure below , the donor cell makes a structure called an F pilus , or sex pilus. The F pilus attaches one cell to another cell. The membranes of the two cells merge and genetic material, usually a plasmid , moves into the recipient cell. Genetic transfer makes bacteria very useful in biotechnology. It can be used to create bacterial cells that carry new genes. What is an answer for this question: Which researcher observed fewer cells "grab" stray pieces of DNA from their environment?
----
Answer: Joe

I have a new situation: Two friends went camping and made a fire each. Bill used a few large logs while Tim used kindlings, wood chips and sawdust. they both brought the same volume of wood. But I can use this background: A large log placed in a fire will burn relatively slowly. If the same mass of wood were added to the fire in the form of small twigs, they would burn much more quickly. This is because the twigs provide a greater surface area than the log does. An increase in the surface area of a reactant increases the rate of a reaction. Surface area is larger when a given amount of a solid is present as smaller particles. A powdered reactant has a greater surface area than the same reactant as a solid chunk. In order to increase the surface area of a substance, it may be ground into smaller particles or dissolved into a liquid. In solution, the dissolved particles are separated from each other and will react more quickly with other reactants. What is an answer for this question: Which friend made a fire that burned faster?
----
Answer: Tim

I have a new situation: Brad and Henry were two old friends in their 70's. Brad had very high levels of cholesterol, while Henry was healthier and had normal levels of cholesterol. But I can use this background: Currently, millions of individuals with high cholesterol take a similar type of drug, known as a statin. The drug, an inhibitor of HMG-CoA reductase (3-hydroxy-3-methyl-glutaryl-CoA reductase), the rate limiting enzyme in cholesterol biosynthesis, decreases blood levels of cholesterol by induce the expression of low density lipoprotein (LDL) receptors in the liver. The increased levels of the LDL-receptors stimulate the catabolism of plasma LDL, removing cholesterol from plasma, which is an important determinant of atherosclerosis. You may know of people who take a statin to help with their cholesterol levels. However, these drugs probably work slightly differently in many of those people. In some, it lowers their cholesterol significantly; in others it may lower it only moderately; and in some, it may have no significant effect at all. (Luckily for those individuals, there are multiple versions of the statins, so different drugs can be tested to find the proper combination for that individual.) Why the difference? Because of the genetic background of all people; the different single nucleotide polymorphisms that make us all different. Pharmacogenomics, a combination of pharmacology and genomics (the study of the genome) that refers to the study of the relationship between pharmaceuticals and genetics, may explain and simplify this problem. What is an answer for this question: Which friend doesn't take an inhibitor of HMG-CoA reductase?
----
Answer:
Henry